Saturday, June 4 | 8:00 AM - 12:00 PM
Upon completion of this activity, the participant will be able to:
1. Discuss key concepts that are predicted to drive the clinical utility of cardiovascular nuclear medicine in the current era.
2. Explain the impact of cost constraints.
3. Identify risks and benefits of radionuclide cardiovascular imaging.
4. Discuss current concepts of vascular molecular imaging.
Mehran M. Sadeghi, MD, Yale University School of Medicine in New Haven, Conn.;
Ronald G. Schwartz, MD, University of Rochester Medical Center in Rochester, N.Y.;
Robert A. deKemp, PhD, University of Ottawa Heart Institute in Ottawa, Ontario;
Marcelo F. Di Carli, MD, Brigham & Women's Hospital in Boston;
Jamshid Maddahi, MD, University of California, Los Angeles;
H. William Strauss, MD, Memorial Sloan Kettering Cancer Center & Memorial Hospital in New York City; and
Daniel S. Berman, MD, Cedars-Sinai Medical Center in Los Angeles.